Skip to main content
. 2021 Jul 26;2021:9972228. doi: 10.1155/2021/9972228

Table 1.

Baseline characteristics and clinical indication.

Baseline characteristics n = 15

Age (yrs) 77.5 ± 6.5
Male 9 (60.0%)
BMI (kg/m2) 26.5 ± 4.1
Congestive heart failure 3 (20.0%)
Hypertension 11 (73.3%)
Age ≥ 75 years 9 (60.0%)
Diabetes mellitus 2 (13.3%)
Previous stroke/TIA 8 (53.3%)
Vascular disease 6 (40.0%)
Permanent AF 11 (73.3%)
Serum creatinine (mg/dl) 1.21 ± 0.63
CHADS-VASc score 4.7 ± 1.0
HAS-BLED score 3.1 ± 0.7

Indications n = 15

Cerebral bleeding 3 (20.0%)
Major bleeding 5 (33.3%)
Minor bleeding 3 (20.0%)
Recurrent stroke under OAC 4 (26.7%)

Numbers are mean ± SD or number (%). AF: atrial fibrillation, BMI: body mass index, OAC: oral anticoagulant, TIA: transient ischemic attack.